Skip to main content
Moderna, Inc. (BVL:MRNAUS)
Peru flag Peru · Delayed Price · Currency is PEN · Price in USD
50.73
-0.21 (-0.41%)
At close: Apr 27, 2026

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of PEN 67.85 billion. The enterprise value is 43.86 billion.

Market Cap 67.85B
Enterprise Value 43.86B

Important Dates

The next confirmed earnings date is Friday, May 1, 2026.

Earnings Date May 1, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 396.59M
Shares Outstanding n/a
Shares Change (YoY) +1.30%
Shares Change (QoQ) +0.51%
Owned by Insiders (%) 6.63%
Owned by Institutions (%) 80.55%
Float 369.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.38
PB Ratio 2.33
P/TBV Ratio 2.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings -4.62
EV / Sales 6.42
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -6.31

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.

Current Ratio 3.29
Quick Ratio 3.06
Debt / Equity 0.15
Debt / EBITDA n/a
Debt / FCF -0.63
Interest Coverage -307.40

Financial Efficiency

Return on equity (ROE) is -28.87% and return on invested capital (ROIC) is -63.28%.

Return on Equity (ROE) -28.87%
Return on Assets (ROA) -14.51%
Return on Invested Capital (ROIC) -63.28%
Return on Capital Employed (ROCE) -29.70%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1.39M
Profits Per Employee -2.02M
Employee Count 4,700
Asset Turnover 0.15
Inventory Turnover 29.63

Taxes

In the past 12 months, Moderna has paid 181.67 million in taxes.

Income Tax 181.67M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +354.19% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +354.19%
50-Day Moving Average 46.56
200-Day Moving Average 35.33
Relative Strength Index (RSI) 82.28
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 7.08

Income Statement

In the last 12 months, Moderna had revenue of PEN 6.54 billion and -9.49 billion in losses. Loss per share was -24.41.

Revenue 6.54B
Gross Profit -6.92B
Operating Income -10.34B
Pretax Income -9.31B
Net Income -9.49B
EBITDA -9.62B
EBIT -10.34B
Loss Per Share -24.41

Balance Sheet

The company has 19.51 billion in cash and 4.39 billion in debt, giving a net cash position of 22.98 billion.

Cash & Cash Equivalents 19.51B
Total Debt 4.39B
Net Cash 22.98B
Net Cash Per Share n/a
Equity (Book Value) 29.10B
Book Value Per Share 73.86
Working Capital 15.33B

Cash Flow

In the last 12 months, operating cash flow was -6.30 billion and capital expenditures -645.93 million, giving a free cash flow of -6.95 billion.

Operating Cash Flow -6.30B
Capital Expenditures -645.93M
Depreciation & Amortization 752.29M
Net Borrowing 2.04B
Free Cash Flow -6.95B
FCF Per Share n/a

Margins

Gross margin is -105.76%, with operating and profit margins of -158.13% and -145.16%.

Gross Margin -105.76%
Operating Margin -158.13%
Pretax Margin -142.39%
Profit Margin -145.16%
EBITDA Margin -147.07%
EBIT Margin -158.13%
FCF Margin n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.30%
Shareholder Yield -1.30%
Earnings Yield -13.99%
FCF Yield -10.24%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Moderna has an Altman Z-Score of 2.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.44
Piotroski F-Score 1